Please assess the completion status of the following clinical trial:

Trial Title: Symptom Control Satisfaction With Proton Pump Inhibitor Regimen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 18 years old~* taking omeprazole 20 mg~* episodic heartburn at least 3 times per week~* provides consent and be willing to complete study questionnaires~* read, speak and write English~Exclusion Criteria:~* weight loss (alarm symptom)~* normal esophagogastroduodenoscopy (EGD) in last one year~* pregnant or women planning on becoming pregnant at any time during the study~* history of Barrett's esophagus~* prior esophageal strictures~* intolerance/allergy to study medications~* patients on plavix or a history of upper gastrointestinal surgery~* investigators or their immediate family (spouse, children, sibling)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Sub-optimal dosing (Type: NO_INTERVENTION): No change will be made to the sub-optimal dosing regimen of omeprazole 20 mg. Rescue antacid use is permitted. Total duration of 6 weeks.
- Optimal dosing (Type: EXPERIMENTAL): Patients will be administered optimal dosing regimen of Omeprazole 20 mg for 4 weeks starting at week 2. Rescue antacid use is permitted. Total duration of 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).